B-cell precursor acute lymphoblastic leukemia elicits an interferon-α/β response in bone marrow-derived mesenchymal stroma

Haematologica. 2024 Jul 1;109(7):2073-2084. doi: 10.3324/haematol.2023.283494.

Abstract

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) can hijack the normal bone marrow microenvironment to create a leukemic niche which facilitates blast cell survival and promotes drug resistance. Bone marrow-derived mesenchymal stromal cells (MSC) mimic this protective environment in ex vivo co-cultures with leukemic cells obtained from children with newly diagnosed BCP-ALL. We examined the potential mechanisms of this protection by RNA sequencing of flow-sorted MSC after co-culture with BCP-ALL cells. Leukemic cells induced an interferon (IFN)-related gene signature in MSC, which was partially dependent on direct cell-cell signaling. The signature was selectively induced by BCP-ALL cells, most profoundly by ETV6-RUNX1-positive ALL cells, as co-culture of MSC with healthy immune cells did not provoke a similar IFN signature. Leukemic cells and MSC both secreted IFNα and IFNβ, but not IFNγ. In line, the IFN gene signature was sensitive to blockade of IFNα/β signaling, but less to that of IFNγ. The viability of leukemic cells and level of resistance to three chemotherapeutic agents was not affected by interference with IFN signaling using selective IFNα/β inhibitors or silencing of IFN-related genes. Taken together, our data suggest that the leukemia-induced expression of IFNα/β-related genes by MSC does not support survival of BCP-ALL cells but may serve a different role in the pathobiology of BCP-ALL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Child
  • Coculture Techniques*
  • Core Binding Factor Alpha 2 Subunit
  • Drug Resistance, Neoplasm
  • ETS Translocation Variant 6 Protein
  • Gene Expression Profiling
  • Gene Expression Regulation, Leukemic
  • Humans
  • Interferon-alpha* / pharmacology
  • Interferon-beta* / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Mesenchymal Stem Cells* / pathology
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / pathology
  • Signal Transduction
  • Transcriptome
  • Tumor Microenvironment

Substances

  • Interferon-alpha
  • Interferon-beta
  • TEL-AML1 fusion protein
  • Oncogene Proteins, Fusion
  • ETS Translocation Variant 6 Protein
  • Core Binding Factor Alpha 2 Subunit